When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharma in Sen. Sanders' crosshairs over Firdapse pricing; shares down 4% premarket
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (NASDAQ:CPRX) is down 4% premarket on light volume on the heels of the news that Sen. Bernie Sanders (I-VT) has sent it a letter asking why Firdapse (amifampridine), approved by the FDA about two months ago for the treatment of a rare autoimmune disorder called Lambert-Eaton myasthenic syndrome, costs $375K when patients were previously getting it for free.